Equity Analysis

Profit & Loss

    Biogen Pharmachem Industries Ltd
    Industry :  Finance & Investments
    BSE Code
    ISIN Demat
    Book Value()
    531752
    INE703D01023
    0.8483681
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    77.01
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    1
    0
     
Particulars(INCOME)Mar 2024
( Cr)
Mar 2023
( Cr)
Mar 2022
( Cr)
Mar 2021
( Cr)
Mar 2020
( Cr)
Mar 2019
( Cr)
Operating Income0.790.002.471.620.000.95
Other Income 1.590.910.010.000.000.00
Total Income2.380.912.481.620.000.95
EXPENDITURE :
Operating Expenses & Administrative Expenses 0.350.282.111.600.080.92
Miscellaneous Expenses 0.000.000.321.610.000.00
Interest 0.020.000.000.000.000.00
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Employee Cost 0.080.170.050.010.040.04
Total Expenditure0.450.452.483.220.120.96
Gross Profit1.930.46-0.01-1.60-0.120.00
Depreciation 0.000.000.000.000.000.00
Profit Before Tax1.930.46-0.01-1.60-0.120.00
Tax0.000.000.000.000.000.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.000.000.000.000.000.00
Reported Net Profit1.930.46-0.01-1.60-0.120.00
Extraordinary Items 1.590.660.000.000.000.00
Adjusted Net Profit0.34-0.20-0.01-1.60-0.120.00
Adjustment below Net Profit 0.000.000.000.001.590.00
P & L Balance brought forward-10.67-11.13-11.12-9.51-10.99-10.98
Appropriations 0.000.000.000.000.000.00
P & L Balance carried down-8.74-10.67-11.13-11.12-9.51-10.99
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.000.00
Dividend Per Share(Rs)0.000.000.000.000.000.00
Earnings Per Share-Unit Curr0.030.010.00-0.020.000.00
Earnings Per Share(Adj)-Unit Curr0.030.010.00-0.020.000.00
Book Value-Unit Curr0.870.840.830.830.850.83
Book Value(Adj)-Unit Curr0.870.840.830.830.850.83